Annual ROA
-48.09%
+38.86%+44.69%
December 31, 2023
Summary
- As of February 23, 2025, MRKR annual return on assets is -48.09%, with the most recent change of +38.86% (+44.69%) on December 31, 2023.
- During the last 3 years, MRKR annual ROA has risen by +14.84% (+23.58%).
- MRKR annual ROA is now -42.66% below its all-time high of -33.71%, reached on December 31, 2016.
Performance
MRKR ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-72.09%
-5.59%-8.41%
September 30, 2024
Summary
- As of February 23, 2025, MRKR quarterly return on assets is -72.09%, with the most recent change of -5.59% (-8.41%) on September 30, 2024.
- Over the past year, MRKR quarterly ROA has stayed the same.
- MRKR quarterly ROA is now -113.18% below its all-time high of 546.91%, reached on June 30, 2016.
Performance
MRKR Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
MRKR ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.7% | 0.0% |
| 3 y3 years | +23.6% | 0.0% |
| 5 y5 years | +89.1% | 0.0% |
MRKR ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.7% | -131.3% | at low |
| 5 y | 5-year | -21.8% | +44.7% | -131.3% | at low |
| alltime | all time | -42.7% | +99.8% | -113.2% | +99.8% |
Marker Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -72.09%(+8.4%) |
| Jun 2024 | - | -66.50%(+113.3%) |
| Mar 2024 | - | -31.17%(-18.2%) |
| Dec 2023 | -48.09%(-44.7%) | -38.09%(+6.4%) |
| Sep 2023 | - | -35.80%(-15.1%) |
| Jun 2023 | - | -42.18%(-34.2%) |
| Mar 2023 | - | -64.15%(-2.0%) |
| Dec 2022 | -86.95%(+41.5%) | -65.49%(-1.1%) |
| Sep 2022 | - | -66.20%(-1.0%) |
| Jun 2022 | - | -66.86%(+7.1%) |
| Mar 2022 | - | -62.45%(+15.2%) |
| Dec 2021 | -61.46%(-2.3%) | -54.23%(-4.4%) |
| Sep 2021 | - | -56.74%(+4.9%) |
| Jun 2021 | - | -54.09%(+0.8%) |
| Mar 2021 | - | -53.66%(-13.3%) |
| Dec 2020 | -62.93%(+59.3%) | -61.88%(+16.4%) |
| Sep 2020 | - | -53.16%(+11.1%) |
| Jun 2020 | - | -47.85%(+7.8%) |
| Mar 2020 | - | -44.37%(+13.4%) |
| Dec 2019 | -39.50%(-91.0%) | -39.12%(-88.1%) |
| Sep 2019 | - | -327.50%(-18.2%) |
| Jun 2019 | - | -400.29%(-27.3%) |
| Mar 2019 | - | -550.37%(-38.6%) |
| Dec 2018 | -439.54%(+162.2%) | -896.30%(+234.0%) |
| Sep 2018 | - | -268.37%(+23.8%) |
| Jun 2018 | - | -216.82%(+18.2%) |
| Mar 2018 | - | -183.38%(+23.7%) |
| Dec 2017 | -167.64%(+397.3%) | -148.20%(+24.8%) |
| Sep 2017 | - | -118.78%(+11.9%) |
| Jun 2017 | - | -106.13%(+5515.3%) |
| Mar 2017 | - | -1.89%(-94.8%) |
| Dec 2016 | -33.71%(-96.6%) | -36.31%(-7.9%) |
| Sep 2016 | - | -39.41%(-107.2%) |
| Jun 2016 | - | 546.91%(-167.2%) |
| Mar 2016 | - | -813.94%(-14.6%) |
| Dec 2015 | -991.77%(-95.2%) | -952.69%(-31.7%) |
| Sep 2015 | - | -1395.53%(-74.9%) |
| Jun 2015 | - | -5557.76%(+1158.4%) |
| Mar 2015 | - | -441.64%(-96.9%) |
| Dec 2014 | -20.49 K%(+204.4%) | -14.34 K%(-14.3%) |
| Sep 2014 | - | -16.74 K%(-44.1%) |
| Jun 2014 | - | -29.96 K%(+15.2%) |
| Mar 2014 | - | -26.01 K%(+488.7%) |
| Dec 2013 | -6730.43%(+133.1%) | -4418.97%(+29.5%) |
| Sep 2013 | - | -3411.96%(-9.4%) |
| Jun 2013 | - | -3764.91%(-42.6%) |
| Mar 2013 | - | -6558.12%(+37.6%) |
| Dec 2012 | -2886.86% | -4766.04%(+66.2%) |
| Sep 2012 | - | -2867.41%(+2.7%) |
| Jun 2012 | - | -2792.36%(+147.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | -1129.07%(-28.6%) |
| Dec 2011 | -888.63%(-40.5%) | -1581.68%(-24.6%) |
| Sep 2011 | - | -2097.47%(+61.6%) |
| Jun 2011 | - | -1297.96%(-24.8%) |
| Mar 2011 | - | -1725.74%(+20.7%) |
| Dec 2010 | -1492.45%(-82.6%) | -1430.28%(-50.5%) |
| Sep 2010 | - | -2892.05%(-7.8%) |
| Jun 2010 | - | -3135.67%(-76.2%) |
| Mar 2010 | - | -13.20 K%(-7.8%) |
| Dec 2009 | -8587.52%(+549.2%) | -14.32 K%(-39.5%) |
| Sep 2009 | - | -23.68 K%(-13.8%) |
| Jun 2009 | - | -27.46 K%(+310.0%) |
| Mar 2009 | - | -6698.78%(+50.7%) |
| Dec 2008 | -1322.79%(-26.3%) | -4444.61%(+47.4%) |
| Sep 2008 | - | -3015.59%(+36.9%) |
| Jun 2008 | - | -2202.80%(+42.4%) |
| Mar 2008 | - | -1546.38%(-15.8%) |
| Dec 2007 | -1795.58%(+68.1%) | -1836.41%(+36.2%) |
| Sep 2007 | - | -1348.73%(-2.4%) |
| Jun 2007 | - | -1381.25%(+36.2%) |
| Mar 2007 | - | -1014.19%(+69.5%) |
| Dec 2006 | -1068.32%(-3.9%) | -598.24%(+14.2%) |
| Sep 2006 | - | -523.86%(+3.7%) |
| Jun 2006 | - | -505.10%(+64.6%) |
| Mar 2006 | - | -306.90%(+4.5%) |
| Dec 2005 | -1111.58%(-62.4%) | -293.68%(-42.2%) |
| Sep 2005 | - | -507.97%(+9.7%) |
| Jun 2005 | - | -462.99%(-8.3%) |
| Mar 2005 | - | -505.08%(-62.4%) |
| Dec 2004 | -2958.35%(+118.8%) | -1344.06%(-31.1%) |
| Sep 2004 | - | -1949.46%(-22.1%) |
| Jun 2004 | - | -2502.45%(-5.9%) |
| Mar 2004 | - | -2659.18%(+52.4%) |
| Dec 2003 | -1352.37%(+172.6%) | -1745.30%(+37.1%) |
| Sep 2003 | - | -1272.97%(+29.0%) |
| Jun 2003 | - | -986.52%(+0.1%) |
| Mar 2003 | - | -985.38%(+0.1%) |
| Dec 2002 | -496.19%(+80.8%) | -984.59%(-21.8%) |
| Sep 2002 | - | -1259.60%(+13.6%) |
| Jun 2002 | - | -1108.59%(+162.0%) |
| Mar 2002 | - | -423.17%(-18.7%) |
| Dec 2001 | -274.42%(-71.4%) | -520.65%(-45.9%) |
| Sep 2001 | - | -962.79%(+22.9%) |
| Jun 2001 | - | -783.61%(-10.9%) |
| Mar 2001 | - | -879.73%(+21.6%) |
| Dec 2000 | -960.22%(+26.3%) | -723.61%(+48.1%) |
| Sep 2000 | - | -488.48%(+73.3%) |
| Jun 2000 | - | -281.80%(+79.5%) |
| Mar 2000 | - | -156.99% |
| Dec 1999 | -760.15% | - |
FAQ
- What is Marker Therapeutics annual return on assets?
- What is the all time high annual ROA for Marker Therapeutics?
- What is Marker Therapeutics annual ROA year-on-year change?
- What is Marker Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Marker Therapeutics?
- What is Marker Therapeutics quarterly ROA year-on-year change?
What is Marker Therapeutics annual return on assets?
The current annual ROA of MRKR is -48.09%
What is the all time high annual ROA for Marker Therapeutics?
Marker Therapeutics all-time high annual return on assets is -33.71%
What is Marker Therapeutics annual ROA year-on-year change?
Over the past year, MRKR annual return on assets has changed by +38.86% (+44.69%)
What is Marker Therapeutics quarterly return on assets?
The current quarterly ROA of MRKR is -72.09%
What is the all time high quarterly ROA for Marker Therapeutics?
Marker Therapeutics all-time high quarterly return on assets is 546.91%
What is Marker Therapeutics quarterly ROA year-on-year change?
Over the past year, MRKR quarterly return on assets has changed by 0.00% (0.00%)